The Biology of Scars — And What Actually Changes Them

Every scar tells a story. A childhood fall, a surgical incision, an acne breakout that went deeper than it should have. Skin heals — but it rarely heals invisibly, and there's a reason for that.

Scarring is not a failure of your biology. It's a rapid-repair strategy, a trade-off the body makes when the priority is closure rather than restoration. Understanding that trade-off is the first step toward influencing it.

This article covers the full arc: the molecular biology of wound healing, why some injuries become permanent marks while others fade, what conventional medicine offers, and where newer peptide-based approaches — particularly BPC-157 and GHK-Cu — fit into an evidence-informed protocol.

The Four Phases of Wound Healing

Your skin doesn't just seal a wound — it orchestrates a remarkably precise sequence of cellular and molecular events. Researchers divide this process into four overlapping phases, each with distinct chemistry and cellular players.

Phase 1: Hemostasis (Minutes to Hours)

The moment tissue is damaged, the body's first goal is to stop bleeding. Platelets rush to the wound site, aggregate, and form a provisional clot. Simultaneously, damaged cells release chemical signals — including thromboxane A2 and prostaglandins — that trigger vasoconstriction to slow blood flow.

Within minutes, a fibrin mesh forms over the wound. This temporary scaffold is far more than a bandage — it's a signaling platform that recruits the cellular machinery needed for everything that follows.

Key players: Platelets, fibrin, thrombin, clotting factors, tissue factor.

Phase 2: Inflammation (Hours to Days)

Inflammation is not the enemy — it's the cleanup crew. Neutrophils arrive first, clearing bacterial contamination and cellular debris via phagocytosis. They're followed by macrophages, which are arguably the most important cells in wound healing: they not only continue debris clearance but also release growth factors (VEGF, TGF-β, FGF) that orchestrate the next phase.

This phase typically peaks around 48–72 hours and should begin resolving within a week in a healthy wound. Chronic inflammation — caused by infection, poor glycemic control, or inadequate nutrition — disrupts this timeline and is one of the primary drivers of excessive scarring.

Key players: Neutrophils, macrophages, cytokines (IL-1β, TNF-α), growth factors (TGF-β1, VEGF).

Phase 3: Proliferation (Days to Weeks)

Once the wound is clean, rebuilding begins. Fibroblasts — the master builders of connective tissue — migrate into the wound bed and begin synthesizing new collagen (primarily Type III, a more flexible provisional form). Blood vessels grow back through a process called angiogenesis, driven by VEGF signaling. Keratinocytes at the wound edges proliferate and migrate inward to re-establish the epithelial barrier.

The result of proliferation is granulation tissue: a highly vascularized, collagen-rich temporary structure that fills the wound. In this phase, the wound gains tensile strength rapidly. But granulation tissue is not normal skin — it lacks the organized architecture that makes skin resilient and invisible.

Key players: Fibroblasts, keratinocytes, VEGF, FGF, Type III collagen, fibronectin.

Phase 4: Remodeling (Months to Years)

This is the phase that determines long-term scar appearance — and the one where most interventions have their effect. Over 12–24 months, the provisional Type III collagen network is slowly replaced with Type I collagen, which is stronger and more organized. Matrix metalloproteinases (MMPs) degrade the old scaffolding while TIMPs (tissue inhibitors of metalloproteinases) regulate the rate of breakdown.

In optimal healing, the remodeled tissue approaches (but never fully matches) the random, basket-weave collagen architecture of normal dermis. The scar gradually flattens, softens, and fades — though this process is highly variable between individuals and wound types.

Key players: Type I collagen, MMPs, TIMPs, myofibroblasts, TGF-β3.

Why Scars Form: The Biology of Imperfect Repair

Normal skin has a specific collagen architecture: fibers arranged in random basket-weave patterns that give skin its flexibility and visual uniformity. Scar tissue, by contrast, has collagen fibers aligned in parallel — functionally adequate for closure, but visually and structurally distinct.

The key molecular driver of excessive scarring is TGF-β1 (Transforming Growth Factor beta-1). High TGF-β1 activity promotes aggressive fibroblast proliferation and collagen deposition — useful when you need to close a wound fast, but counterproductive when it overshoots. TGF-β3, by contrast, promotes more regenerative, less fibrotic healing and is the target of several research-stage therapies.

Types of Scars

Not all scars are alike. Understanding the type you're dealing with shapes the treatment approach:

Conventional Scar Treatments: What the Evidence Says

The market for scar treatments is large and often oversold. Here's an honest, evidence-grounded breakdown of the most common approaches.

Silicone Sheets and Gels

Silicone remains the most evidence-backed non-invasive scar intervention. Multiple randomized controlled trials show that silicone gel sheeting reduces hypertrophic scar height, erythema, and pliability. The mechanism isn't fully understood but likely involves hydration of the stratum corneum and modulation of TGF-β expression in dermal fibroblasts.

Effectiveness: Best for hypertrophic scars within the first 12 months. Needs consistent daily use (12+ hours/day) for 2–3 months. Less effective for keloids and atrophic scars.

Affiliate note: High-quality silicone gel sheeting (like these medical-grade options on Amazon) should be medical-grade silicone, not cosmetic grade. Look for products with clinical study backing.

Vitamin E

Vitamin E's reputation as a scar treatment significantly outpaces its evidence base. A 1999 double-blind RCT found vitamin E either made no difference or worsened cosmetic outcomes compared to placebo — and caused contact dermatitis in a notable percentage of subjects. The intuitive rationale (antioxidant = less scarring) doesn't translate well in practice.

Verdict: Low evidence. Not recommended as a standalone scar treatment. If you want antioxidant support, topical vitamin C (ascorbic acid) has more compelling data for skin remodeling, particularly in combination with other actives.

Laser Resurfacing

Laser treatments — particularly fractional CO₂, Nd:YAG, and pulsed-dye laser — are among the most clinically validated interventions for scar remodeling. They work by creating controlled micro-injuries that stimulate the wound healing cascade, specifically inducing new collagen synthesis in the remodeling phase.

• Fractional CO₂: Gold standard for atrophic acne scars. Significant improvement in scar depth and texture, typically requiring 3–5 sessions. Downtime 5–10 days per session.
• Pulsed-Dye Laser (PDL): Targets hemoglobin — particularly effective for red/vascular hypertrophic scars. Reduces erythema and raises. Minimal downtime.
• Nd:YAG: Better for darker skin tones where CO₂ carries hyperpigmentation risk.

Lasers don't eliminate scars — they stimulate enough remodeling to improve their appearance by 50–75% in responsive cases. Cost runs $300–$2,000+ per session depending on modality and clinic.

Microneedling

Microneedling (collagen induction therapy) uses fine needles to create microchannels in the dermis, triggering a wound healing response without significant epidermal damage. It's particularly effective for atrophic scars and is one of the more accessible procedures: in-office RF microneedling runs $600–$1,500/session; at-home dermarollers (0.25–0.5mm rollers for at-home use) are available for $20–$80 though depth is significantly limited compared to clinical devices.

Research consistently shows improvement in rolling and boxcar acne scars with 3–6 sessions spaced 4–6 weeks apart. Combining microneedling with topical actives (vitamin C serums, growth factors, peptide serums) takes advantage of the transient permeability increase to improve penetration.

Important: At-home microneedling at ≤0.5mm is primarily for product absorption enhancement. Deeper remodeling requires clinical needle depths (1.5–2.5mm) administered by a professional.

Surgical Scar Revision

For mature scars that haven't responded to conservative management, surgical revision (subcision, punch excision, TCA cross for ice-pick scars) can produce meaningful structural improvements. Subcision physically breaks up fibrotic bands that tether atrophic scars to underlying tissue, allowing the skin to spring back.

Surgery carries risk of creating new scars, particularly in keloid-prone individuals, and should be a late-stage option after exhausting less invasive approaches. Best results often combine surgical revision with subsequent laser resurfacing sessions.

The Peptide Angle: BPC-157 and GHK-Cu

Beyond conventional aesthetics, a small but growing body of research points to peptides as tools for influencing wound healing biology at a more fundamental level — not just stimulating the skin's surface response, but modulating the underlying molecular signals that determine how tissue rebuilds.

Two peptides stand out for their relevance to scarring and wound healing.

BPC-157: Systemic Tissue Repair

BPC-157 (Body Protection Compound-157) is a 15-amino-acid synthetic peptide derived from a protein found in gastric juice. While much of the clinical interest in BPC-157 centers on gut healing and musculoskeletal repair, its wound-healing properties are among its best-documented effects across animal research.

In preclinical studies, BPC-157 has been shown to:

• Accelerate wound closure: Rodent studies show significantly faster re-epithelialization and granulation tissue formation in BPC-157-treated wounds compared to controls.
• Upregulate growth hormone receptors: BPC-157 appears to sensitize tissue to growth hormone signaling, which may partly explain its regenerative effects across multiple tissue types.
• Stimulate angiogenesis: Via VEGF upregulation, BPC-157 promotes new blood vessel formation — critical for delivering oxygen and nutrients to healing tissue during the proliferative phase.
• Modulate collagen synthesis: Studies in tendon and skin models suggest BPC-157 influences collagen organization, potentially toward more organized (less fibrotic) deposition.
• Reduce inflammation without immunosuppression: Unlike corticosteroids, BPC-157 appears to modulate the inflammatory response without the side effects of broad immune suppression — relevant for scar prevention since excess inflammation is a key driver of hypertrophic outcomes.

For skin healing specifically, both topical and systemic (subcutaneous or oral) routes have shown activity in animal models. Human clinical data is limited — BPC-157 remains a research peptide, not an FDA-approved therapeutic — but the mechanistic rationale for its use in wound care is coherent with its known biology.

For a comprehensive overview of BPC-157's research profile, pharmacology, and dosing considerations, read our BPC-157 complete guide. If you're also interested in gut healing (where BPC-157 has perhaps its strongest research base), the BPC-157 + KPV gut healing stack article is worth reading alongside this one.

GHK-Cu: Copper Peptide and Scar Remodeling

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma, urine, and saliva. Plasma levels peak in early adulthood and decline with age — a pattern that correlates with the well-documented age-related decline in skin quality and wound healing speed.

GHK-Cu's role in wound healing and scar remodeling is arguably more directly relevant than BPC-157's, given its long research history in skin biology. Key findings include:

• Stimulates collagen, elastin, and glycosaminoglycan synthesis: GHK-Cu activates fibroblast activity, leading to increased production of the structural proteins that give skin its firmness and elasticity. This is the core mechanism behind its use in anti-aging serums.
• Activates MMP remodeling: GHK-Cu uniquely stimulates both collagen production and the MMPs (matrix metalloproteinases) that break down old, damaged collagen. This dual action promotes tissue turnover and remodeling — replacing fibrotic scar tissue with more organized matrix over time.
• Anti-fibrotic activity: Multiple studies show GHK-Cu suppresses TGF-β1 activity — the same growth factor responsible for excessive scar formation. By attenuating TGF-β1 while promoting TGF-β3 (pro-regenerative), GHK-Cu tips the healing balance away from fibrosis.
• Antioxidant and anti-inflammatory: GHK-Cu scavenges free radicals and modulates inflammatory cytokines, helping resolve the inflammatory phase cleanly rather than prolonging it into the chronic state that promotes excess scarring.
• Stem cell activation: Emerging research suggests GHK-Cu may activate stem cell populations involved in skin regeneration, including dermal papilla cells relevant to skin appendage recovery.

For scar treatment, GHK-Cu is primarily used topically. Its bioavailability penetrating intact skin is moderate; the microchannels created by microneedling substantially increase delivery depth — making GHK-Cu serums an excellent complement to microneedling protocols.

For a deeper look at GHK-Cu's full research profile and skincare applications, read our GHK-Cu complete guide. We also cover its application specifically for dark spots and uneven tone in our hyperpigmentation deep-dive.

Using Both Together

BPC-157 and GHK-Cu operate through complementary mechanisms — one primarily systemic and regenerative, the other primarily local and remodeling-focused. Used in combination, they address different phases and levels of the healing process.

A rational approach for someone actively recovering from a wound or working on an established scar might combine:

• Systemic BPC-157 (subcutaneous or oral) during the active healing phase for growth factor support and angiogenesis
• Topical GHK-Cu serum applied to the healing tissue throughout both proliferative and remodeling phases
• Microneedling sessions (once wound is fully closed) with GHK-Cu applied immediately post-procedure for enhanced penetration

Note: Neither BPC-157 nor GHK-Cu are FDA-approved. Use is off-label and research-based. Always work with a qualified healthcare provider when incorporating peptides into a recovery protocol.

A Framework for Scar Prevention and Treatment

Scarring is most influenced in two windows: the acute wound healing phase (first 2–4 weeks) and the early remodeling phase (months 1–6). Interventions should be timed accordingly.

Acute Phase (Wound Active or Just Closed)

1. Keep it moist: Moist wound healing (occlusive dressings, medical-grade petroleum jelly) consistently outperforms dry wound care for minimizing scar formation. Don't let new wounds dry out.
2. Minimize inflammation: Good nutrition, blood sugar control, and sleep quality directly affect inflammatory resolution speed. Chronic inflammation = chronic scar risk.
3. Sun protection: UV exposure on healing skin is one of the fastest routes to permanent hyperpigmented scarring. Keep healing wounds covered or protected with high-SPF sunscreen once re-epithelialized.
4. Consider BPC-157: If tissue repair is the priority, the acute phase is when its angiogenic and regenerative effects are most relevant.

Early Remodeling Phase (Months 1–6)

1. Silicone: Start as soon as the wound is fully closed. 12+ hours/day consistently for 2–3 months.
2. Massage: Twice-daily scar massage (with gentle pressure, circular motions) helps break up excess collagen cross-links and soften raised tissue. Simple but evidence-supported.
3. GHK-Cu topical: Applied daily to the scar site once closed. Longer-term use (3–6 months) aligns with the remodeling timeline.
4. First professional evaluation: For hypertrophic or concerning scars, a dermatologist consult at the 4–8 week mark allows early laser intervention while the scar is still responsive.

Established Scars (6+ Months)

1. Laser resurfacing: The highest-evidence procedure for structural improvement in both atrophic and hypertrophic established scars.
2. Microneedling series: 3–6 sessions spaced 4–6 weeks apart. Particularly effective for atrophic acne scarring.
3. GHK-Cu + microneedling: Combining the two capitalizes on temporary increased skin permeability post-procedure.
4. Surgical revision: For ice-pick acne scars (TCA cross, punch excision) or tethered atrophic scars (subcision) that haven't responded to other approaches.

What Not to Do

A few common practices that the evidence doesn't support — or actively contradicts:

• Picking or manipulating healing wounds: Disrupts the organized phase sequence and dramatically increases scar risk.
• Hydrogen peroxide on wounds: Cytotoxic to fibroblasts. Impairs healing rather than helping it. Use saline for wound cleansing.
• Vitamin E oil: As covered above, evidence is weak to negative. Skip it.
• Aggressive exfoliation on healing skin: Active retinoids, AHAs, and physical scrubs on a healing wound disrupt re-epithelialization.
• Impatience: Scar remodeling takes 12–24 months. Most people give up long before the biological process completes. The single most underappreciated scar treatment is consistent time.

The Skincare Pillar: How This Fits

Wound healing and scarring are the structural foundation of skin repair biology. The mechanisms covered here — collagen synthesis, MMP remodeling, growth factor signaling, inflammation resolution — connect directly to the broader landscape of skin aging and repair.

For the underlying science of collagen decline and what drives long-term skin quality, read The Science of Collagen Loss and How to Rebuild Your Skin. For the specific challenge of post-inflammatory hyperpigmentation (one of the most common scar sequelae), see our guide to dark spots and uneven skin tone.

Frequently Asked Questions

The Bottom Line

Scar formation is a biological program with multiple intervention points — and most people engage with it either too late (after the scar has matured) or with tools that aren't well matched to the stage of healing they're in.

The honest hierarchy: moist wound care and sun protection during acute healing, silicone and massage through early remodeling, professional laser or microneedling for established scars. Peptides — particularly GHK-Cu topically and BPC-157 systemically — add a meaningful layer for those who want to optimize at the molecular level, though they work best as complements to evidence-based fundamentals rather than replacements for them.

Skin heals. The question is how well — and the answer is more within your control than most people realize.